menu
    • menu

    Company profile for Tagworks Pharmaceuticals

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tagworks Pharmaceuticals, pioneer of the Click-to-Release approach, is a precision therapy company, leveraging its technology platform, which is protected by a broad patent estate, to develop a new standard of care for patients suffering from severe diseases including cancer. Tagworks is developing a pipeline of click-cleavable therapies. Its lead program, TGW101, is an antibody-drug conjugate (ADC) targeting TAG72, a clinical...
    Tagworks Pharmaceuticals, pioneer of the Click-to-Release approach, is a precision therapy company, leveraging its technology platform, which is protected by a broad patent estate, to develop a new standard of care for patients suffering from severe diseases including cancer. Tagworks is developing a pipeline of click-cleavable therapies. Its lead program, TGW101, is an antibody-drug conjugate (ADC) targeting TAG72, a clinically-validated, pan-carcinoma target that so far has remained out of reach of current ADC therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tagworks PharmaceuticalsNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Toernooiveld 1 6525 ED Nijmegen
    Telephone
    Telephone
    +31 85 800 8550
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tagworkspharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tagworks-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tagworks Pharma Initiates Phase 0/1 Clinical Trial For TGW211
    Tagworks Pharma Initiates Phase 0/1 Clinical Trial For TGW211

    15 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tagworks-pharmaceuticals-announces-cta-authorization-and-initiation-of-phase-01-clinical-trial-for-tgw211-a-radiopharmaceutical-for-the-treatment-of-her2-tumors-302584061.html

    PR NEWSWIRE
    15 Oct 2025
    Share Share
    Tagworks Starts Third Dose Level in TGW101 Ph 1 Trial for Tumors
    Tagworks Starts Third Dose Level in TGW101 Ph 1 Trial for Tumors

    09 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tagworks-pharmaceuticals-announces-initiation-of-third-dose-level-in-ongoing-phase-1-clinical-trial-of-tgw101-for-the-treatment-of-solid-tumors-302550607.html

    PR NEWSWIRE
    09 Sep 2025
    Share Share
    Tagworks Gets FDA IND OK, Starts Ph 1 for TGW101
    Tagworks Gets FDA IND OK, Starts Ph 1 for TGW101

    22 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tagworks-pharmaceuticals-announces-fda-clearance-of-ind-application-and-initiation-of-phase-1-clinical-trial-for-tgw101-and-appoints-keith-orford-md-phd-as-chief-medical-officer-302433670.html

    PR NEWSWIRE
    22 Apr 2025
    Share Share
    Tagworks Appoints Ken Mills as CEO
    Tagworks Appoints Ken Mills as CEO

    01 Oct 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com//contents/view_breaking-news/2024-10-01/tagworks-appoints-ken-mills-as-ceo/?widget=listSection

    CONTRACT PHARMA
    01 Oct 2024
    Share Share
    Tagworks Pharmaceuticals Names Ken Mills CEO
    Tagworks Pharmaceuticals Names Ken Mills CEO

    01 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tagworks-pharmaceuticals-appoints-ken-mills-as-chief-executive-officer-302263854.html

    PR NEWSWIRE
    01 Oct 2024
    Share Share
    Tagworks Pharma Announces $65 M in Series A Financing
    Tagworks Pharma Announces $65 M in Series A Financing

    22 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tagworks-pharmaceuticals-announces-65-million-in-series-a-financing-to-advance-click-to-release-therapeutics-301857548.html

    PR NEWSWIRE
    22 Jun 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search